NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI™ (aviptadil) in NIH ...

Retrieved on: 2021-08-18 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI™ (aviptadil) in NIH .... View article details on hiswai:

Excerpt

ACTIV-3 is a randomized, blinded, placebo-controlled clinical trial testing ZYESAMI™ and the antiviral remdesivir (Veklury) in hospitalized patients ...

Article found on: www.mdjonline.com

View Original Article